ITPKA
Inositol-trisphosphate 3-kinase A
Also known as: IP3-3KA, IP3KA, IP3KA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23677
- Gene
- ITPKA
- Ensembl
- ENSG00000137825
- Chromosome
- 15
- Canonical length
- 461 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles,Plasma membrane
OverviewNCBI Gene
Regulates inositol phosphate metabolism by phosphorylation of second messenger inositol 1,4,5-trisphosphate to Ins(1,3,4,5)P4. The activity of the inositol 1,4,5-trisphosphate 3-kinase is responsible for regulating the levels of a large number of inositol polyphosphates that are important in cellular signaling. Both calcium/calmodulin and protein phosphorylation mechanisms control its activity. It is also a substrate for the cyclic AMP-dependent protein kinase, calcium/calmodulin- dependent protein kinase II, and protein kinase C in vitro.[provided by RefSeq, Apr 2011]
Canonical amino-acid sequenceUniProt
461 residues, UniProt reviewed canonical sequence.
>P23677|ITPKA
1 MTLPGGPTGM ARPGGARPCS PGLERAPRRS VGELRLLFEA RCAAVAAAAA AGEPRARGAK
61 RRGGQVPNGL PRAPPAPVIP QLTVTAEEPD VPPTSPGPPE RERDCLPAAG SSHLQQPRRL
121 STSSVSSTGS SSLLEDSEDD LLSDSESRSR GNVQLEAGED VGQKNHWQKI RTMVNLPVIS
181 PFKKRYAWVQ LAGHTGSFKA AGTSGLILKR CSEPERYCLA RLMADALRGC VPAFHGVVER
241 DGESYLQLQD LLDGFDGPCV LDCKMGVRTY LEEELTKARE RPKLRKDMYK KMLAVDPEAP
301 TEEEHAQRAV TKPRYMQWRE GISSSTTLGF RIEGIKKADG SCSTDFKTTR SREQVLRVFE
361 EFVQGDEEVL RRYLNRLQQI RDTLEVSEFF RRHEVIGSSL LFVHDHCHRA GVWLIDFGKT
421 TPLPDGQILD HRRPWEEGNR EDGYLLGLDN LIGILASLAE RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ITPKA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 57 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 57 nTPM
- basal ganglia: 45 nTPM
- amygdala: 30 nTPM
- hippocampal formation: 26 nTPM
- small intestine: 17 nTPM
- duodenum: 17 nTPM
Single-cell type
- late spermatids: 301 nCPM
- megakaryocytes: 62 nCPM
- foveolar cells: 57 nCPM
- colonocytes: 55 nCPM
- early spermatids: 45 nCPM
- late primary spermatocytes: 42 nCPM
Immune cell
- MAIT T-cell: 1.4 nTPM
- gdT-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- cerebral cortex: 42 nTPM
- basal ganglia: 35 nTPM
- amygdala: 24 nTPM
- hippocampal formation: 23 nTPM
- white matter: 21 nTPM
- cerebellum: 8.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0.65
- gnomAD missense Z
- 1.57
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- cellular response to calcium ion
- dendritic spine maintenance
- inositol metabolic process
- inositol phosphate biosynthetic process
- modification of postsynaptic actin cytoskeleton
- phosphatidylinositol phosphate biosynthetic process
- positive regulation of dendritic spine morphogenesis
- regulation of synaptic plasticity
- response to calcium ion
- signal transduction
Molecular functions
- ATP binding
- calcium/calmodulin-dependent protein kinase activity
- calmodulin binding
- inositol hexakisphosphate kinase activity
- inositol-1,4,5-trisphosphate 3-kinase activity
- small GTPase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ITPKA as an antibody target. Whether an autoantibody or antibody against ITPKA could matter depends on whether native ITPKA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ITPKA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ITPKA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...